VIRI - Pendapatan operasional sadurunge ngurangi amortisasi virios.com

Virios Therapeutics evolved through a merger with a vaccine developer to integrate research capabilities. The positive trend in EBITDA confirms the success of the IMC-1 therapy against fibromyalgia and long COVID. Growth potential is based on FDA approvals and distribution contracts, while the indicator remains at , demonstrating the business's current cash strength.

VIRI - Bathi operasional sadurunge ngurangi amortisasi Virios Therapeutics Inc. ing rentang 04.07.2022 - 14.11.2026

Virios Therapeutics, Inc. - rincian analitis lan metrik utama (VIRI)

- rega saham lan target rega konsensus:

Bagan rega Virios Therapeutics Inc.|VIRI - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Kapitalisasi pasar Virios Therapeutics|VIRI - Nilai Total Perusahaan

- data ekuitas miturut neraca:

Nilai Akuntansi Saham Virios Therapeutics|VIRI - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku virios.com|VIRI - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

Koefisien Total Utang marang Modal Virios Therapeutics|VIRI - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Virios Therapeutics Inc.|VIRI - Gunggung utang perusahaan|Utang-utang marang aset resik Virios Therapeutics|VIRI - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Virios Therapeutics|Koefisien jangkoan perantara virios.com

- statistik bathi lan rasio pasar:

VIRI - Bathi resik perusahaan|Bathi resik sing dikarepake Virios Therapeutics|VIRI - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi Virios Therapeutics Inc.|VIRI - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Virios Therapeutics|VIRI - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Virios Therapeutics|VIRI - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan virios.com|VIRI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Virios Therapeutics

- indikator dodolan lan pendapatan:

VIRI - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan Virios Therapeutics Inc.|VIRI - Multiplikator P/S|Multiplikator Forward P/S Virios Therapeutics

Ringkesan analitik perusahaan:VIRI Virios Therapeutics

Produk mawa merek Virios Therapeutics Inc.

Professional selection of sustainable assets requires an analysis of operational efficiency excluding debt load and depreciation. This absolute cash result of operations measures the net cash flow from operating activities, where for Virios Therapeutics (VIRI) the stability of this metric confirms the success of laboratory modernization and the implementation of digital trial monitoring under strict environmental control.

Pesaing Virios Therapeutics (VIRI)